IART Dividend: Integra Lifesciences Holdings Corp Yield Insights

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	1,642	1,610	1,541	1,557	1,542	1,371
Revenue Growth (YoY)	5%	4%	-1%	1%	12%	-10%
Cost of Revenue	702	656	569	575	565	486
Gross Profit	940	954	972	982	977	885
Selling, General & Admin	670	663	602	595	606	564
Research & Development	86	94	85	79	75	74
Operating Expenses	772	771	700	689	698	666
Other Non Operating Income (Expenses)	-1	4	4	16	24	4
Pretax Income	-545	-18	81	213	214	93
Income Tax Expense	-49	-11	13	33	45	-40
Net Income	-495	-6	67	180	169	133
Net Income Growth	8,150%	-109%	-63%	7%	27%	166%
Shares Outstanding (Diluted)	76.75	77.01	80.33	83.5	85.5	85.2
Shares Change (YoY)	0%	-4%	-4%	-2%	0%	-2%
EPS (Diluted)	-6.45	-0.09	0.84	2.16	1.98	1.57
EPS Growth	7,231%	-111%	-61%	9%	26%	171%
Free Cash Flow	-14	15	73	217	264	139
Free Cash Flow Per Share	-0.18	0.19	0.9	2.59	3.08	1.63
Gross Margin	57.24%	59.25%	63.07%	63.07%	63.35%	64.55%
Operating Margin	10.17%	11.3%	17.58%	18.81%	18.02%	15.9%
Profit Margin	-30.14%	-0.37%	4.34%	11.56%	10.95%	9.7%
Free Cash Flow Margin	-0.85%	0.93%	4.73%	13.93%	17.12%	10.13%
EBITDA	181	196	283	306	294	245
EBITDA Margin	11.02%	12.17%	18.36%	19.65%	19.06%	17.87%
D&A For EBITDA	14	14	12	13	16	27
EBIT	167	182	271	293	278	218
EBIT Margin	10.17%	11.3%	17.58%	18.81%	18.02%	15.9%
Effective Tax Rate	8.99%	61.11%	16.04%	15.49%	21.02%	-43.01%

Integra Lifesciences Holdings Corp (IART) Price